These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25345737)

  • 1. Quantitative levels of aripiprazole parent drug and metabolites in urine.
    McEvoy J; Millet RA; Dretchen K; Morris AA; Corwin MJ; Buckley P
    Psychopharmacology (Berl); 2014 Dec; 231(23):4421-8. PubMed ID: 25345737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients.
    Molden E; Lunde H; Lunder N; Refsum H
    Ther Drug Monit; 2006 Dec; 28(6):744-9. PubMed ID: 17164689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of an Optimal Dose of Aripiprazole in the Treatment of Schizophrenia From Plasma Concentrations of Aripiprazole Plus Its Active Metabolite Dehydroaripiprazole at Week 1.
    Nagai G; Mihara K; Nakamura A; Nemoto K; Kagawa S; Suzuki T; Kondo T
    Ther Drug Monit; 2017 Feb; 39(1):62-65. PubMed ID: 27861318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP1A2*F Polymorphism Contributes at Least Partially to the Variability of Plasma Levels of Dehydroaripiprazole, an Active Metabolite of Aripiprazole, in Schizophrenic Patients.
    Suzuki T; Nagai G; Mihara K; Tomori Y; Kagawa S; Nakamura A; Nemoto K; Kondo T
    Drug Metab Bioanal Lett; 2024; 17(1):7-12. PubMed ID: 37855290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients.
    Kim JR; Seo HB; Cho JY; Kang DH; Kim YK; Bahk WM; Yu KS; Shin SG; Kwon JS; Jang IJ
    Br J Clin Pharmacol; 2008 Dec; 66(6):802-10. PubMed ID: 19032724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of aripiprazole and concomitant carbamazepine.
    Citrome L; Macher JP; Salazar DE; Mallikaarjun S; Boulton DW
    J Clin Psychopharmacol; 2007 Jun; 27(3):279-83. PubMed ID: 17502775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophrenia.
    Bachmann CJ; Rieger-Gies A; Heinzel-Gutenbrunner M; Hiemke C; Remschmidt H; Theisen FM
    Ther Drug Monit; 2008 Aug; 30(4):462-6. PubMed ID: 18641558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of comedication on serum concentrations of aripiprazole and dehydroaripiprazole.
    Waade RB; Christensen H; Rudberg I; Refsum H; Hermann M
    Ther Drug Monit; 2009 Apr; 31(2):233-8. PubMed ID: 19142178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients.
    Huang HC; Liu CH; Lan TH; Hu TM; Chiu HJ; Wu YC; Tseng YL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):57-61. PubMed ID: 17602901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genetic deficiencies of P-glycoprotein and breast cancer resistance protein on pharmacokinetics of aripiprazole and dehydroaripiprazole.
    Nagasaka Y; Sano T; Oda K; Kawamura A; Usui T
    Xenobiotica; 2014 Oct; 44(10):926-32. PubMed ID: 24666334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of acute and sub-chronic aripiprazole in P-glycoprotein deficient mice.
    Kirschbaum KM; Uhr M; Holthoewer D; Namendorf C; Pietrzik C; Hiemke C; Schmitt U
    Neuropharmacology; 2010 Nov; 59(6):474-9. PubMed ID: 20599439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier.
    Nagasaka Y; Oda K; Iwatsubo T; Kawamura A; Usui T
    Biopharm Drug Dispos; 2012 Sep; 33(6):304-15. PubMed ID: 22847220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of aripiprazole and its active metabolite, dehydroaripiprazole, in plasma by capillary electrophoresis combining on-column field-amplified sample injection and application in schizophrenia.
    Hwang PL; Wei SY; Yeh HH; Ko JY; Chang CC; Chen SH
    Electrophoresis; 2010 Aug; 31(16):2778-86. PubMed ID: 20665528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovering interactions in augmentation strategies: Impact of duloxetine on the metabolism of aripiprazole.
    Margraff T; Schoretsanitis G; Neuner I; Haen E; Gaebler AJ; Paulzen M
    Basic Clin Pharmacol Toxicol; 2023 Jul; 133(1):73-81. PubMed ID: 37069136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of aripiprazole and dehydroaripiprazole in hair segments from deceased individuals with mental disorders.
    Rygaard K; Linnet K; Banner J; Johansen SS
    Forensic Sci Int; 2020 Dec; 317():110523. PubMed ID: 33010563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies.
    Akamine Y; Yasui-Furukori N; Kojima M; Inoue Y; Uno T
    J Sep Sci; 2010 Nov; 33(21):3292-8. PubMed ID: 21049519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole in patients with schizophrenia.
    Nakamura A; Mihara K; Nagai G; Suzuki T; Kondo T
    Ther Drug Monit; 2009 Oct; 31(5):575-8. PubMed ID: 19701114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
    Citrome L; Josiassen R; Bark N; Salazar DE; Mallikaarjun S
    J Clin Pharmacol; 2005 Jan; 45(1):89-93. PubMed ID: 15601809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: an open-label, parallel-arm, multiple-dose study.
    Mallikaarjun S; Kane JM; Bricmont P; McQuade R; Carson W; Sanchez R; Forbes RA; Fleischhacker WW
    Schizophr Res; 2013 Oct; 150(1):281-8. PubMed ID: 23890595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.